viral respiratory infection prophylactic therapy (NanoBio)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameviral respiratory infection prophylactic therapy (NanoBio)
Drug Alias Name20N10 nanoemulsion (NanoBio)8N8 nanoemulsion (NanoBio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRespirovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBluewillow Biologics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBluewillow Biologics Inc
Active IndicationsN/A
Inactive IndicationsRespirovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A